Dr France Docquier with fellow scientists Dr Sushma Rai and Dr Christina Greenwood
Press release issued: 6 November 2009
"We have discovered there are two different types of CTCF: a 'good' CTCF found in healthy breast tissues and a 'bad' CTCF found in cancerous breast tissues."
"The study indicates the two versions of the protein perform different functions in normal and cancerous breast cells. We showed that the 'bad' protein helps the breast cells to grow, but when cells stop growing the 'good' protein is present. Our findings are very exciting as they could result in a change in how breast cancer is treated in future years. New therapies could be developed to re-establish the 'good' protein, potentially resulting in the cancer cells becoming more like normal cells."
"This is fantastic news - the study has uncovered some fresh details on breast cancer which may offer patients access to new treatment options in the future. As a charity we are very pleased to know the contributions we receive from the community have resulted in a breast cancer breakthrough. It truly is an exciting time in the world of cancer research and treatment development and the charity is committed to joint-fund its cancer research laboratory with Anglia Ruskin University, Chelmsford, Essex."
The Helen Rollason Cancer Charity lab in Anglia Ruskin University, Chelmsford, Essex, will be holding an open day on January 20, 2010 from 10am-4pm. The public is welcome to attend the open day to find out more about the laboratory and the charity.